Harry J. Crijns
Distinguished in Atrial Fibrillation

Harry J. Crijns

Maastricht, LI, NL 
Distinguished in Atrial Fibrillation
Maastricht, LI, NL 
OverviewLocationsClinical Research

Overview

Harry Crijns practices in Maastricht, Netherlands. Mr. Crijns is rated as a Distinguished expert by MediFind in the treatment of Atrial Fibrillation. His top areas of expertise are Atrial Fibrillation, Heart Block, Heart Failure, Cardiac Ablation, and Heart Transplant.

His clinical research consists of co-authoring 408 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 286 articles and participated in 3 clinical trials in the study of Atrial Fibrillation.

Gender
Male

Locations

Maastricht, LI, Netherlands
Other Locations
Utrecht, UT 3531AH, Netherlands
Nijmegen, GE, Netherlands
St. Antonius Hospital, The Hague, St. Franciscus Gasthuis, Eindhoven, NB, Netherlands
Tilburg, NB, Netherlands
Cardiology & Carim, Netherlands
Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation
A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: Flecainide Acetate
Study Phase: Phase 2
Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study
Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study
Enrollment Status: Terminated
Publish Date: March 12, 2020
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department (RACE 7 ACWAS-trial)
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department (RACE 7 ACWAS-trial)
Enrollment Status: Completed
Publish Date: January 21, 2020
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
IntegRAted Chronic Care Program at a Specialized Atrial Fibrillation (AF) Clinic Versus Usual CarE in Patients With Atrial Fibrillation, an Investigator-initiated, Prospective, Randomised, Open Label, Blinded Outcome Assessment (PROBE) Controlled Multi-center Study
IntegRAted Chronic Care Program at a Specialized Atrial Fibrillation (AF) Clinic Versus Usual CarE in Patients With Atrial Fibrillation, an Investigator-initiated, Prospective, Randomised, Open Label, Blinded Outcome Assessment (PROBE) Controlled Multi-center Study
Enrollment Status: Completed
Publish Date: May 28, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

408 Total Publications

Correction to: Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis.
Correction to: Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis.
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Crijns's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile